Ann M Sheehy Selected Research

vif Gene Products

11/2004	Further investigation of simian immunodeficiency virus Vif function in human cells.
8/2004	Cytidine deamination of retroviral DNA by diverse APOBEC proteins.
11/2003	The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
8/2002	Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann M Sheehy Research Topics

Disease

5	Infections 11/2004 - 08/2002
2	Hypertension (High Blood Pressure) 05/2014 - 01/2014
2	Critical Illness (Critically Ill) 01/2010 - 05/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2003 - 08/2002
1	Heart Failure 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 11/2009
1	Glucose Intolerance 05/2009
1	Hyperglycemia 05/2009
1	Virus Diseases (Viral Diseases) 08/2002

Drug/Important Bio-Agent (IBA)

4	vif Gene ProductsIBA 11/2004 - 08/2002
3	Proteins (Proteins, Gene)FDA Link 11/2003 - 08/2002
2	Antihypertensive Agents (Antihypertensives)IBA 05/2014 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2010 - 05/2009
2	DNA (Deoxyribonucleic Acid)IBA 11/2003 - 06/2003
1	Insulin (Novolin)FDA Link 05/2009
1	DeoxyuridineIBA 11/2003
1	DeoxycytidineIBA 11/2003
1	Complementary DNA (cDNA)IBA 11/2003
1	APOBEC-1 DeaminaseIBA 11/2003

Therapy/Procedure

3	Therapeutics 05/2009 - 08/2002
2	Glycemic Control 11/2009 - 05/2009
1	Patient Readmission 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Spinal Injections 01/2020
1	Radiotherapy 01/2020